Growth Metrics

Carlsmed (CARL) Other Non-Current Liabilities (2024 - 2026)

Carlsmed posted quarterly Other Non-Current Liabilities of $327000.0 for Q1 2026, up 5.83% on a QoQ basis from $309000.0 in Q4 2025.

Carlsmed (CARL) has 3 years of Other Non-Current Liabilities data on file, last reported at $327000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $327000.0; the trailing twelve-month figure through Mar 2026 stood at $327000.0 (changed N/A YoY), and the FY2025 full-year result was $309000.0, down 32.39% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $327000.0, up from $309000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $727000.0 in Q2 2025 and bottomed at $290000.0 in Q3 2025.
  • The 3-year median for Other Non-Current Liabilities is $327000.0 (2026), against an average of $422000.0.
  • Peak annual rise in Other Non-Current Liabilities reached 32.39% in 2025, while the deepest fall reached 32.39% in 2025.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $457000.0 in 2024, then tumbled by 32.39% to $309000.0 in 2025, then advanced by 5.83% to $327000.0 in 2026.
  • The last three Other Non-Current Liabilities figures came in at $327000.0 (Q1 2026), $309000.0 (Q4 2025), and $290000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 Carlsmed 298.68 Mn 201.48 Mn 12.43 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 327,000.00
Dec 31, 2025 309,000.00
Sep 30, 2025 290,000.00
Jun 30, 2025 727,000.00
Dec 31, 2024 457,000.00